Evidence map›Paper›PMID 40458263›Full record

ArticlePCN reports : psychiatry and clinical neurosciences2025

[

Andrea Sturchio, Jonas E Svensson, Mikael Tiger, Anton Forsberg Morén, Andrea Varrone, Per Svenningsson, Yoshiro Okubo, Amane Tateno

Abstract read
In one paragraph

Article in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [PCN reports : psychiatry and clinical neurosciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea SturchioDepartment of Clinical Neuroscience, Neuro Svenningsson Karolinska Institute Stockholm Sweden.ORCID https://orcid.org/0000-0002-1067-2834
Jonas E SvenssonDepartment of Clinical Neuroscience Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm Stockholm Sweden.
Mikael TigerDepartment of Clinical Neuroscience Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm Stockholm Sweden.
Anton Forsberg MorénDepartment of Clinical Neuroscience Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm Stockholm Sweden.
Andrea VarroneDepartment of Clinical Neuroscience Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm Stockholm Sweden.
Per SvenningssonDepartment of Clinical Neuroscience, Neuro Svenningsson Karolinska Institute Stockholm Sweden.
Yoshiro OkuboDepartment of Neuropsychiatry Nippon Medical School Tokyo Japan.
Amane TatenoDepartment of Neuropsychiatry Nippon Medical School Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Dementia with Lewy bodies (DLB) is characterized by motor and non-motor symptoms. The degeneration of the dopaminergic pathway is a hallmark of DLB; for this reason, we aimed to study a recent dopamine transporter (DAT) positron emission tomography (PET) radioligand as a diagnostic tool for DLB. Methods: In this study, we used DAT-PET with the radioligand [ Results: Binding potential ( Conclusion: Our study showed that [

Indexed as

[18F]FE‐PE2Idementia with Lewy bodiesdopamine transporter (DAT) imagingneurodegenerationneuroimaging

Identifiers

PMID40458263
PMCPMC12128163

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.